The LBI for Lung Vascular Research has substantial expertise in the basic mechanisms of pulmonary vascular constriction and remodelling, combined with a broad and profound clinical background.
We aim to provide a significant contribution to early recognition of pulmonary vascular diseases including pulmonary hypertension via novel and non-invasive methods and to develop innovative therapeutic strategies for an improved prognosis and better quality of life for the victims of this serious disease. The integrative, multidisciplinary and translational structure of the LBI-LVR allows it to uncover underlying molecular pathways, identify distinct targets for reverse-remodelling therapy, foster drug development based on these targets, and prove these new treatment options in preclinical and clinical proof-of-concept trials.
Awards at the ÖGP annual meeting for the LBI-LVR
At the 46th Annual Meeting of the Austrian Society of Pneumology (ÖGP), which took place from Sep…
46. ÖGP Annual conference
There are more and more patients suffering from pulmonary hypertension. Around one per cent of pe…
Research against pathological changes in the lungs
Pulmonary fibrosis is a serious disease that causes dramatic changes in lung tissue, including ha…